Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Finished Goods: 2016-2024

  • Zepp Health's Finished Goods fell 31.92% to $45.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $45.8 million, marking a year-over-year decrease of 31.92%. This contributed to the annual value of $45.8 million for FY2024, which is 31.92% down from last year.
  • Per Zepp Health's latest filing, its Finished Goods stood at $45.8 million for Q4 2024, which was down 31.92% from $67.3 million recorded in Q4 2023.
  • Zepp Health's 5-year Finished Goods high stood at $116.1 million for Q4 2021, and its period low was $45.8 million during Q4 2024.
  • In the last 3 years, Zepp Health's Finished Goods had a median value of $67.3 million in 2023 and averaged $74.9 million.
  • As far as peak fluctuations go, Zepp Health's Finished Goods spiked by 46.98% in 2020, and later slumped by 39.72% in 2023.
  • Over the past 5 years, Zepp Health's Finished Goods (Quarterly) stood at $92.1 million in 2020, then climbed by 26.03% to $116.1 million in 2021, then declined by 3.84% to $111.7 million in 2022, then plummeted by 39.72% to $67.3 million in 2023, then plummeted by 31.92% to $45.8 million in 2024.
  • Its Finished Goods stands at $45.8 million for Q4 2024, versus $67.3 million for Q4 2023 and $111.7 million for Q4 2022.